Clinical Trials
8
Active:6
Completed:2
Trial Phases
2 Phases
Phase 1:4
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (80.0%)Phase 2
1 (20.0%)Safety Study of Vx006 Vaccine in Solid Tumor Patients
Phase 1
Completed
- Conditions
- Solid Tumor
- First Posted Date
- 2014-11-13
- Last Posted Date
- 2019-06-19
- Lead Sponsor
- Vaxon Biotech
- Target Recruit Count
- 23
- Registration Number
- NCT02289196
- Locations
- 🇬🇷
251 General Airforce Hospital, Athens, Greece
🇬🇷Iaso General Hospital, Athens, Greece
🇬🇷University General Hospital of Heraklion, Heraklion, Crete, Greece
Efficacy Study of Vx001 Vaccine in NSCLC Patients
Phase 2
Completed
- Conditions
- Non-small Cell Lung Cancer Metastatic
- Interventions
- Drug: Placebo
- First Posted Date
- 2013-09-04
- Last Posted Date
- 2019-06-19
- Lead Sponsor
- Vaxon Biotech
- Target Recruit Count
- 221
- Registration Number
- NCT01935154
- Locations
- 🇨🇿
Fakultni nemocnice Plzen, Plzen-Bory, Czechia
🇨🇿Vseobecna fakultni nemocnice, Praha 2, Czechia
🇫🇷University Hospital of Angers, Angers, France
News
No news found